ArticleThe American journal of pathology2017

Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer.

Elisabetta Puliga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.